SERUM ISCHEMIA-MODIFIED ALBUMIN AS AN OXIDATIVE STRESS BIOMARKERIN LUNG TUBERCULOSIS PATIENT

Aim: The goal of this study was to investigateischemia-modified albumin (IMA) as a novel marker of oxidative stress in tuberculosis patients.Materials andmethods:Our study included 49patients with active lung tuberculosis and 45healthy controls. Serum IMAwas measured with automated spectrometric methodand results were compared statistically.Results:We found that IMA levels were significantly higher in pulmonary tuberculosis patients than in the control group. Albumin levels were significantly lower in the patient group than in the control group.Conclusion:The study showed that we can use this parameter as a new oxidative stress marker in the pathogenesis of pulmonary tuberculosis.